MRNA - Risk

Pure Price Volatility Risk (Market Swings)

The business itself is financially solid (Financial Health 80/100, minimal insolvency risk). The high overall score (7/7) is driven primarily by extreme stock price swings (±104.0% p.a.) and steep historical drawdowns.

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

7/7 Very High

7 / 7 SRI Price Fluctuation & Beta

Very high volatility or fundamental risks. Significant loss potential; strictly for aggressive investors. Largely moves in line with the broader market.

Beta (Market Relation)

1.1x

Above average

Volatility (5Y p.a.)

104.0% p.a.

5-Year Horizon

Max Drawdown (5Y)

-93.9%

5-Year Horizon

Sharpe Ratio

-0.10

Return / Risk

Speculative / High Risk: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Volatility Expansion (3Y > 5Y) High Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	+605.6%
3 Years	123.0%	-86.6%	0.18	+24.6%
5 Years	104.0%	-93.9%	-0.1	-8.4%
10 Years	96.5%	-95.4%	0.34	—

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Exemplary balance sheet strength: Very solid ratio of equity to debt.

Elevated Short-Term Volatility: 3Y volatility (123.0%) is noticeably higher than the 5Y average (104.0%).

Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (104.0% p.a.).

Historical Stress Test: Maximum peak-to-trough drawdown of -95.4% in the extended horizon.